-
FDA proclaims meals dye ban
Candy is displayed for sale, as U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., along with FDA Commissioner Marty Makary, announce the FDA’s intent to remove from the U.S. food supply “petroleum-based synthetic” food dyes, which are present in numerous foods such as breakfast cereals, candy, snacks, and beverages, at a grocery…
-
Eli Lilly weight reduction tablet orforglipron clears first late-stage trial
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular injections on the market. The trial results are among the pharmaceutical industry’s most closely watched studies…
-
UnitedHealth makes docs repay loans issued after Change cyberattack
UnitedHealth CEO Andrew Witty testifies before the Senate Finance Committee on Capitol Hill in Washington, May 1, 2024. Kent Nishimura | Getty Images Following the massive cyberattack on UnitedHealth Group’s Change Healthcare unit last year, the company launched a temporary funding assistance program to help medical practices with their short-term cash flow needs, offering no-interest…
-
CMS makes job cuts as RKF Jr. guts HHS
An aerial of the Centers for Medicare & Medicaid Services building on March 19, 2025 in Woodlawn, Maryland. Kayla Bartkowski | Getty Images The Centers for Medicare & Medicaid Services has slashed jobs from its minority health office and other divisions, CNBC has learned, as Robert F. Kennedy Jr. upends the U.S. health department. During…
-
Europe’s pharma {industry} braces for tariffs as carve-out hopes fade
SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT JFK AIRPORT’S INTERNATIONAL MAIL FACILITY. CNBC COPENHAGEN, Denmark — Europe’s pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by U.S. President Donald Trump fade. The pharmaceutical industry has until now been exempt from trade levies, but Trump…
-
We’re shopping for extra shares of two shares because the broader market sinks additional
We’re making our first trades of the week. We are buying 25 shares of Danaher at roughly $207 each. Following Friday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to 3.5% from 3.35%. We are buying 10 shares of Home Depot at roughly $358. Following the trade, the Trust…
-
AstraZeneca to speculate $2.5 billion in Beijing hub
AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators’ scrutiny over its import duties. The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees. The investment in Beijing comes as part of…
-
Wegovy is linked to an elevated danger of hair loss, research suggests
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.…
-
White Home pulls Trump CDC Director nominee Dave Weldon
Former Congressman Dave Weldon addresses a small crowd in The Villages, Fla. Brendan Farrington | AP The White House has pulled President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, former Rep. Dave Weldon, the Senate’s health committee confirmed Thursday. The move came just hours before the former Florida lawmaker, a…
-
Hinge Well being to go public as quickly as April, supply says
Hinge Health’s TrueMotion feature. Courtesy: Hinge Health Digital physical therapy startup Hinge Health is gearing up to file for an initial public offering, potentially as soon as next week, CNBC has learned. Hinge Health helps patients with musculoskeletal injuries ranging from minor sprains to chronic pain recover from the comfort of their own homes. Its IPO…
